Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-01

Clinical Trial Update: Cellulose Powder Against Grass Pollen Allergic Rhinitis [Phase 2, Phase 3]

View source ↗

Summary

Update on Phase 2 and Phase 3 trials evaluating cellulose powder for grass pollen-induced allergic rhinitis, conducted by Nasaleze International Ltd, which have…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cellulose powder nasal spray (cellulose powder)

Snippet

Sponsor: Nasaleze International Ltd | Conditions: Allergic Rhinitis | Phase 2, Phase 3 | Status: COMPLETED